The applicant, Dr. Cyrus Zabetian, has spent the past three years as a postdoctoral fellow at Yale University/ VACHS. He will join the neurology faculty at the University of Washington next year where his future mentors, Drs. Thomas Bird and Gerard Schellenberg, have established a superb research program in neurogenetics. His training will include participation in laboratory meetings, seminars, structured courses, and annual scientific meetings. He will become part of a rich collaborative network of researchers with expertise in clinical and molecular neurogenetics, catecholamine biochemistry, and biostatistics. Dr. Zabetian's long-term plans are to become established as an independent laboratory investigator within five years, and remain actively involved in patient care and resident training on the neurology service. In neurodegenerative disease research, identifying genetic mechanisms underlying compensatory changes in surviving neurons promises to lead to improved strategies of diagnosis and treatment. The project proposed in this application seeks to determine if a newly discovered promoter polymorphism (C-1021T) influences regulation of the DBH gene with potential clinical consequences in Parkinson's disease (PD), and is divided into three parts. The goal of part I is to evaluate whether homozygosity for the T allele of C-1021 T, which is associated with low levels of plasma DBH enzyme, is predictive of an earlier onset and more severe symptoms of sympathetic failure in patients with PD. A group of forty subjects homozygous for either the C or T allele will be selected from a population of 400 clinic patients with PD and assessed longitudinally using indices of sympathetic function. Part II seeks to determine whether C-1021T strongly associates with DBH expression in noradrenergic tissues. Levels of DBH protein and mRNA will be compared in postmortem human adrenal medulla specimens, homozygous for either the C or T allele, using western blots and quantitative real time RT-PCR, respectively. Part III will assess whether C-1021T is directly functional. If preliminary results are favorable, two transgenic mouse lines homozygous for either the T or C allele will be created in which the proximal 2 kb of the endogenous mouse DBH promoter is replaced by homologous human sequence. Comparing plasma and tissue levels of DBH protein and catecholamines in the two lines will detect the effect of each allele on DBH expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08NS044138-04
Application #
6925429
Study Section
NST-2 Subcommittee (NST)
Program Officer
Murphy, Diane
Project Start
2002-08-19
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
4
Fiscal Year
2005
Total Cost
$166,271
Indirect Cost
Name
University of Washington
Department
Neurology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bahner, Florian; Weiss, Elisa K; Birke, Gunnar et al. (2011) Cellular correlate of assembly formation in oscillating hippocampal networks in vitro. Proc Natl Acad Sci U S A 108:E607-16
Payami, Haydeh; Kay, Denise M; Zabetian, Cyrus P et al. (2010) Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease. Genet Epidemiol 34:92-9
Mata, Ignacio F; Hutter, Carolyn M; González-Fernández, María C et al. (2009) Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics 10:347-53
Zabetian, Cyrus P; Yamamoto, Mitsutoshi; Lopez, Alexis N et al. (2009) LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord 24:1034-41
Healy, Daniel G; Falchi, Mario; O'Sullivan, Sean S et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7:583-90
Hutter, Carolyn M; Samii, Ali; Factor, Stewart A et al. (2008) Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. Eur J Neurol 15:134-9
Haugarvoll, K; Rademakers, R; Kachergus, J M et al. (2008) Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70:1456-60
Mata, Ignacio F; Samii, Ali; Schneer, Seth H et al. (2008) Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 65:379-82
Powers, Karen M; Kay, Denise M; Factor, Stewart A et al. (2008) Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord 23:88-95
McCulloch, Colin C; Kay, Denise M; Factor, Stewart A et al. (2008) Exploring gene-environment interactions in Parkinson's disease. Hum Genet 123:257-65

Showing the most recent 10 out of 26 publications